Related Experiment Videos
Costimulation pathways in host immune responses to allogeneic hepatocytes
G L Bumgardner1, J Li, M Heininger
1Department of Surgery, The Ohio State University and Medical Center, Columbus 43210, USA.
Transplantation
|January 12, 1999
Summary
Blocking the CD40/CD40L pathway with MR1 significantly prolonged allogeneic hepatocyte survival in mice, indicating its critical role in T-cell immune responses. The CD28/B7 pathway, blocked by CTLA4Ig, did not show a similar effect.
Area of Science:
- Immunology
- Transplantation Biology
- Molecular Medicine
Background:
- Investigates the crucial role of costimulatory pathways in T-cell mediated immune responses to allogeneic hepatocytes.
- Focuses on the CD28/B7 (CTLA4Ig) and CD40/CD40L (MR1) pathways.
Purpose of the Study:
- To determine the impact of blocking CD28/B7 and CD40/CD40L costimulation on the survival of allogeneic hepatocytes in vivo.
- To elucidate the specific contributions of these pathways to T-cell dependent immune responses.
Main Methods:
- Utilized a mouse model with allogeneic hepatocytes (H-2q) transplanted into C57BL/6 (H-2b) mice.
- Administered MR1, CTLA4Ig, a control protein (L6), or a combination of MR1 and CTLA4Ig.
- Monitored the survival time of hepatocellular allografts in different treatment groups.
Main Results:
- MR1 treatment significantly prolonged hepatocellular allograft survival (median 84 days) compared to untreated controls (median 10 days).
- CTLA4Ig treatment showed a modest, though statistically significant, prolongation of allograft survival (median 10 days).
- Combined MR1 and CTLA4Ig treatment also significantly prolonged survival (median 84 days).
Conclusions:
- CD40/CD40L interactions are critical for T-cell dependent immune responses against allogeneic hepatocytes.
- CD28/B7 costimulation appears less important for these specific immune responses.
- Targeting the CD40/CD40L pathway offers a promising strategy for enhancing allograft survival.